Commentary: Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela)
Saved in:
| Main Authors: | Matthew Warren Brunke, Curtis Wells Dewey |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Veterinary Science |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2025.1628681/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global pharmacovigilance reporting of the first monoclonal antibody for canine osteoarthritis: a case study with bedinvetmab (Librela™)
by: Beatriz P. Monteiro, et al.
Published: (2025-04-01) -
A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis
by: John F. Innes, et al.
Published: (2025-03-01) -
Pharmacovigilance of lower urinary tract adverse events among commonly prescribed medications: A FAERS database analysis
by: Robert Adler, et al.
Published: (2025-06-01) -
Heat therapy in rheumatic and musculoskeletal diseases – an overview of clinical and molecular effects
by: Philipp Klemm, et al.
Published: (2024-12-01) -
GENERAL PRINCIPLES OF TREATMENT FOR MUSCULOSKELETAL PAIN: INTERDISCIPLINARY CONSENSUS
by: E. L. Nasonov, et al.
Published: (2016-07-01)